Q2 2025 Holdings
Filed 2025-08-13 | 439 holdings | $295.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ituran Location and Control(ITRN) | SHS | M6158M104 | $186.7K | 4,820 | 0.1% |
| Ryerson Hldg Corp(RYI) | COM | 783754104 | $192.8K | 8,940 | 0.1% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $203.7K | 11,911 | 0.1% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $330.9K | 192,378 | 0.1% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $361.2K | 10,328 | 0.1% |
| Nuveen Churchill Direct Lend(NCDL) | COM SHS | 67090S108 | $363.5K | 22,453 | 0.1% |
| Immunitybio Inc(IBRX) | COM | 45256X103 | $367.8K | 139,309 | 0.1% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $374.7K | 20,574 | 0.1% |
| Morgan Stanley Direct Lendin(MSDL) | COM SHS | 61774A103 | $381.5K | 20,380 | 0.1% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $382.9K | 42,730 | 0.1% |
| Beone Medicines LTD(ONC) | SPONSORED ADS | 07725L102 | $389.0K | 1,607 | 0.1% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $391.4K | 12,472 | 0.1% |
| Novavax Inc(NVAX) | COM NEW | 670002401 | $391.6K | 62,153 | 0.1% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $399.4K | 23,073 | 0.1% |
| Geron Corp(GERN) | COM | 374163103 | $401.7K | 284,868 | 0.1% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $411.3K | 11,311 | 0.1% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $412.7K | 72,025 | 0.1% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $416.0K | 11,722 | 0.1% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $421.3K | 13,333 | 0.1% |
| Biogen Inc(BIIB) | COM | 09062X103 | $421.9K | 3,359 | 0.1% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $423.9K | 8,148 | 0.1% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $423.9K | 42,730 | 0.1% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $424.9K | 44,306 | 0.1% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $425.7K | 8,717 | 0.1% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $426.5K | 7,758 | 0.1% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $428.0K | 11,892 | 0.1% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $428.4K | 12,881 | 0.1% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $430.1K | 966 | 0.1% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $431.8K | 66,427 | 0.1% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $435.3K | 3,167 | 0.1% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $436.6K | 38,744 | 0.1% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $436.7K | 4,183 | 0.1% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $439.6K | 10,852 | 0.1% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $439.7K | 3,966 | 0.1% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $440.2K | 29,745 | 0.1% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $440.9K | 20,441 | 0.1% |
| Ligand Pharmaceuticals Inc(LGND) | COM NEW | 53220K504 | $441.4K | 3,883 | 0.1% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $443.4K | 16,026 | 0.1% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $445.6K | 7,052 | 0.2% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $446.3K | 1,553 | 0.2% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $446.8K | 3,555 | 0.2% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $447.3K | 852 | 0.2% |
| Moderna Inc(MRNA) | COM | 60770K107 | $448.3K | 16,248 | 0.2% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $448.8K | 2,600 | 0.2% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $451.0K | 4,236 | 0.2% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $452.4K | 1,495 | 0.2% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $457.4K | 53,997 | 0.2% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $461.4K | 9,066 | 0.2% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $461.6K | 4,587 | 0.2% |
| Theravance Biopharma Inc(TBPH) | COM | G8807B106 | $462.0K | 41,884 | 0.2% |